Lebanon, New Hampshire 03766


Purpose:

A patient's sun-related behavior greatly influences the likelihood of that patient developing melanoma, the most dangerous form of skin cancer. Prior research shows current education strategies on inducing preventative behaviors such as wearing sun-protection clothing and wearing sunscreen are inadequate at effectively changing behavior when used in isolation -- patients are aware of the dangers of not engaging in these preventative measures but forgo them nonetheless. We are investigating methods to positively influence sun protection behaviors among melanoma survivors and their families. The first objective is to compare patient and familial sun exposure and cancer screening activity before and after patients' diagnosis with primary melanoma. The second objective is to note if hanging a "Melanoma Survivor" plaque in a melanoma survivor's bathroom will significantly affect the survivor's and broader family's sun exposure and cancer screening activity. Our sample of patients consists of survivors of primary cutaneous melanoma less than 4.0 mm in depth who come through the Dermatology Clinic at Dartmouth-Hitchcock Medical Center and voluntarily choose to participate in the study after being informed of the nature of the research. These patients complete a confidential survey assessing a change in sun exposure related activities immediately after their diagnosis. After they fill out the survey, we will ask them if they could nominate a family member to whom we will explain the purpose of our research and confidentially ask an additional set of questions to evaluate the broader impact of a melanoma diagnosis. From our original sample, we will randomly choose a few families who would display the survivor plaque in their primary bathroom. After six-twelve months, during the patient's follow up visit, will ask again both groups of patients and family members to fill out another survey to assess sun exposure related activity. On the surveys, no names are recorded. Everything is anonymous.


Criteria:

Inclusion Criteria: - patient has melanoma diagnosis within past 10 years less than 4mm in depth Exclusion Criteria:


NCT ID:

NCT02457065


Primary Contact:

Principal Investigator
Michael S Chapman, MD
Dartmouth-Hitchcock Medical Center

Jonathan A Busam, undergrad.
Phone: 862-579-0726
Email: Jonathan.A.Busam@hitchcock.org


Backup Contact:

N/A


Location Contact:

Lebanon, New Hampshire 03766
United States

Pamela Gangar, MD
Phone: 603-653-9500
Email: pamela.gangar@hitchcock.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.